ClinicalTrials.gg
Not yet recruitingNCT07830966Updated Sep 22, 2026

Assessment of Nutritional Status in Critically Ill Children in PICU

An observational study in Malnutrition and Critical Illness, sponsored by Assiut University. Not yet recruiting. Open to participants aged 1 Month to 5 Years. Per ClinicalTrials.gov, last updated 2026-09-22.

Sponsored by Assiut University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
103
Ages
1 Month to 5 Years
Sex
All
01

Study summary

This prospective cohort study aims to assess the nutritional status of critically ill children aged 1 month to 5 years admitted to the pediatric intensive care unit using a comprehensive ABCD approach including anthropometric, biochemical, clinical, and dietary assessment within 48 hours of admission, and to evaluate its association with clinical outcomes including duration of mechanical ventilation, length of PICU stay, and mortality.

Read the detailed description

Malnutrition is common among critically ill children in PICU with prevalence around 37 percent. This study will include children admitted to PICU at Assiut University Children Hospital with expected stay greater than 48 hours. Nutritional status will be assessed within 48 hours using anthropometric measurements weight height body mass index mid-upper arm circumference skinfold thickness, biochemical markers albumin prealbumin total protein C-reactive protein electrolytes, clinical examination for muscle and fat loss, and dietary intake. Children will be followed up to 30 days for clinical outcomes.

02

Conditions studied

  • Malnutrition
  • Critical Illness

Keywords

  • PICU
  • ABCD
  • Pediatric critical care
  • Mechanical ventilation
  • Assiut
  • nutritional assessment
03

In context

Malnutrition

1,277 studies on the registry are indexed under Malnutrition; 230 are open to participants now.

This study's planned enrollment of 103 is below the median of 206 across 393 observational studies indexed under Malnutrition.

Browse Malnutrition studies →

Lead sponsor

Assiut University is the lead sponsor of 5,078 studies on the registry; 2,178 are open to participants now.

Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Month to 5 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Critically ill children aged 1 month to 5 years admitted to PICU at Assiut University Children Hospital

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age from 1 month to 5 years
  • Admitted to PICU with expected length of stay greater than 48 hours
  • Written from parents or legal guardians

Exclusion criteria

Exclusion Criteria:

  • Chronic renal or hepatic disease known to affect serum protein levels
  • Incomplete medical records or discharged or transferred before first laboratory sample could be obtained
  • Receiving nutritional support enteral or parenteral prior to PICU admission for condition unrelated to current critical illness
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
103 participants (estimated)
Patient registry
No

Groups and cohorts

  • Critically ill children in PICU

    Children aged 1 month to 5 years admitted to PICU with expected stay greater than 48 hours who will undergo comprehensive nutritional assessment using ABCD approach within 48 hours of admission

06

What researchers measure

Primary outcomes

  1. Nutritional status at PICU admission assessed by ABCD approach

    Number of children classified as malnourished based on comprehensive ABCD assessment including anthropometric measurements body mass index z-score mid-upper arm circumference skinfold thickness, biochemical markers albumin prealbumin total protein, clinical signs of muscle and fat loss, and dietary intake, obtained within 48 hours of PICU admission

    Time frame: At baseline within 48 hours of admission

Secondary outcomes

  1. Duration of mechanical ventilation

    Length of mechanical ventilation in days

    Time frame: Up to 30 days

  2. Length of PICU stay

    Length of stay in the pediatric intensive care unit in days

    Time frame: Up to 30 days

  3. PICU mortality

    Number of children who die during PICU stay

    Time frame: Up to 30 days

  4. Feeding intolerance and refeeding syndrome

    Number of children who develop feeding intolerance or refeeding syndrome during PICU stay

    Time frame: Up to 30 days

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Tume LN, Valla FV, Joosten K, Jotterand Chaparro C, Latten L, Marino LV, Macleod I, Moullet C, Pathan N, Rooze S, van Rosmalen J, Verbruggen SCAT. Nutritional support for children during critical illness: European Society of Pediatric and Neonatal Intensive Care (ESPNIC) metabolism, endocrine and nutrition section position statement and clinical recommendations. Intensive Care Med. 2020 Mar;46(3):411-425. doi: 10.1007/s00134-019-05922-5. Epub 2020 Feb 20. PubMed 32077997 ↗
  • Hulst JM, Huysentruyt K, Gerasimidis K, Shamir R, Koletzko B, Chourdakis M, Fewtrell M, Joosten KF; Special Interest Group Clinical Malnutrition of ESPGHAN. A Practical Approach to Identifying Pediatric Disease-Associated Undernutrition: A Position Statement from the ESPGHAN Special Interest Group on Clinical Malnutrition. J Pediatr Gastroenterol Nutr. 2022 May 1;74(5):693-705. doi: 10.1097/MPG.0000000000003437. Epub 2022 Mar 3. PubMed 35258497 ↗
  • Abera EG, Sime H. The prevalence of malnutrition among critically ill children: a systematic review and meta-analysis. BMC Pediatr. 2023 Nov 21;23(1):583. doi: 10.1186/s12887-023-04419-x. PubMed 37986053 ↗
  • Agrawal A, Sharma S, Janjua D, Jadon G, Chanchlani R, Dsouza V. Impact of nutritional status on the mortality and clinical outcomes of children admitted to the pediatric intensive care unit: A systematic review and meta-analysis. Clin Nutr. 2025 Aug;51:28-39. doi: 10.1016/j.clnu.2025.06.002. Epub 2025 Jun 6. PubMed 40516325 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07830966
Lead sponsor
Assiut University
Responsible party
Merna Atef Felly (Resident Physician, Pediatrics, Assiut University) — Principal investigator
First posted
Sep 21, 2026
Start date
Sep 20, 2026 (estimated)
Primary completion
Sep 25, 2027 (estimated)
Completion
Jan 10, 2028 (estimated)
Last update
Sep 22, 2026

Study contacts

Merna A Felly, Resident
Contact
mernafelly4@gmail.com
+20 15 51377917
Azza A Eltayeb, prof
study chair · pediatrics Department, Assiut University Hospitals

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion